Vertex Pharmaceuticals (VRTX) Non-Current Assets (2009 - 2026)
Vertex Pharmaceuticals (VRTX) posted Non-Current Assets of $14.9 billion for Q2 2026, up 0.85% on a QoQ basis from $14.8 billion in Q1 2026, and up 9.34% year-over-year from $13.6 billion in Q2 2025.
Powered by 
Analysis
Vertex Pharmaceuticals (VRTX) Non-Current Assets (2009 - 2026) Analysis & Trends
Vertex Pharmaceuticals has reported Non-Current Assets for 18 years, with the latest figure at $14.9 billion in Q2 2026.
- On a quarterly basis, Non-Current Assets rose 9.34% year-over-year to $14.9 billion in Q2 2026; TTM through Jun 2026 was $58.4 billion, a 12.56% increase from a year earlier, with the FY2025 full-year figure at $14.4 billion, up 11.64% from the prior year.
- Non-Current Assets was $14.9 billion for Q2 2026 at Vertex Pharmaceuticals, up from $14.8 billion in the prior quarter.
- The five-year high for Non-Current Assets was $14.9 billion in Q2 2026, with the low at $3.9 billion in Q1 2022.
- Average Non-Current Assets over 5 years is $9.9 billion, with a median of $10.9 billion recorded in 2024.
- The sharpest annual moves came in 2022 and 2024: Non-Current Assets increased 8.36% in 2022, then surged 76.89% in 2024.
- Over 5 years, Non-Current Assets stood at $4.9 billion in 2022, then surged by 74.65% to $8.6 billion in 2023, then jumped by 50.67% to $12.9 billion in 2024, then increased by 11.64% to $14.4 billion in 2025, then rose by 3.03% to $14.9 billion in 2026.
- The last three Non-Current Assets figures came in at $14.9 billion (Q2 2026), $14.8 billion (Q1 2026), and $14.4 billion (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 649.01 Bn | 628.25 Bn | 17.26 Bn | 141.29 Bn |
| 2 | AbbVie | 468.55 Bn | 462.03 Bn | 12.70 Bn | 101.45 Bn |
| 3 | Merck | 365.49 Bn | 358.40 Bn | 12.21 Bn | 125.00 Mn |
| 4 | Novartis Ag | 272.39 Bn | 265.10 Bn | 11.24 Bn | 94.68 Bn |
| 5 | Astrazeneca | 253.18 Bn | 247.96 Bn | 12.86 Bn | 87.87 Bn |
| 6 | Amgen | 219.53 Bn | 205.54 Bn | 7.24 Bn | 60.68 Bn |
| 7 | Gilead Sciences | 187.85 Bn | 184.59 Bn | 6.22 Bn | 35.42 Bn |
| 8 | Pfizer | 160.56 Bn | 149.16 Bn | 10.94 Bn | 159.77 Bn |
| 9 | Vertex Pharmaceuticals | 130.81 Bn | 122.96 Bn | 2.84 Bn | 14.88 Bn |
| 10 | Bristol Myers Squibb | 124.95 Bn | 113.89 Bn | 9.25 Bn | 59.06 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 14.88 Bn |
| Mar 31, 2026 | 14.75 Bn |
| Dec 31, 2025 | 14.44 Bn |
| Sep 30, 2025 | 14.29 Bn |
| Jun 30, 2025 | 13.61 Bn |
| Mar 31, 2025 | 12.87 Bn |
| Dec 31, 2024 | 12.94 Bn |
| Sep 30, 2024 | 12.44 Bn |
| Jun 30, 2024 | 11.19 Bn |
| Mar 31, 2024 | 10.63 Bn |
| Dec 31, 2023 | 8.59 Bn |
| Sep 30, 2023 | 7.03 Bn |
| Jun 30, 2023 | 6.48 Bn |
| Mar 31, 2023 | 6.01 Bn |
| Dec 31, 2022 | 4.92 Bn |
| Sep 30, 2022 | 4.44 Bn |
| Jun 30, 2022 | 4.08 Bn |
| Mar 31, 2022 | 3.89 Bn |
| Dec 31, 2021 | 3.87 Bn |
| Sep 30, 2021 | 3.77 Bn |
API Access
Vertex Pharmaceuticals Non-Current Assets API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=non-current-assets&ticker=VRTX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "non-current-assets", "ticker": "VRTX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=non-current-assets&ticker=VRTX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();